Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Teenage mutant neutrophilic precursors: Leukemia cutis with IDH2 mutation on enasidenib therapy.

Leukemia research - 1 Sept 2020

Kallen Michael E, Koka Rima, Singh Zeba, Sanchez-Petitto Gabriela, Zaman Qamar U, Yared Jean A, Duong Vu H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminopyridines
Share to Isocitrate Dehydrogenase
Share to Leukemia, Myeloid, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neutrophils

Share to Prognosis

Share to Skin Diseases

Share to Triazines

Source

Identifiers

PMID: 32604058
DOI: 10.1016/j.leukres.2020.106406

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Teenage mutant neutrophilic precursors: Leukemia cutis with IDH2 mutation on enasidenib therapy.PMID 32604058Read ↗

Pediatric Acute Lymphoblastic Leukemia With Hypereosinophilia and IDH2 Gene Mutation: A Case Report and Literature Review.Semantic proximity Read ↗

Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenibSemantic proximity Read ↗

Stein EM. IDH2 inhibition in AML. Blood. 2023;141(2):124-125.Semantic proximity Read ↗

Hitting the target in IDH2 mutant AML.Semantic proximity Read ↗

Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials.Semantic proximity Read ↗

A new player in IDH1 mutated myeloid neoplasias.Semantic proximity Read ↗

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis.Semantic proximity Read ↗

Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid LeukemiaSemantic proximity Read ↗

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasmsSemantic proximity Read ↗

T cells take aim in AML: targeting IDH2.Semantic proximity Read ↗

Fish provide ID(H)eas on targeting leukemia.Semantic proximity Read ↗

Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.